APA (7th ed.) Citation

K, A., Y, A., M, M., S, S., R, D., & H, M. (2022). Neoadjuvant lenvatinib for inoperable thyroid cancer: A case report and literature review. Cancer reports (Hoboken, N.J.), 5(2), e1466. https://doi.org/10.1002/cnr2.1466

Chicago Style (17th ed.) Citation

K, Alshehri, Alqurashi Y, Merdad M, Samargandy S, Daghistani R, and Marzouki H. "Neoadjuvant Lenvatinib for Inoperable Thyroid Cancer: A Case Report and Literature Review." Cancer Reports (Hoboken, N.J.) 5, no. 2 (2022): e1466. https://doi.org/10.1002/cnr2.1466.

MLA (9th ed.) Citation

K, Alshehri, et al. "Neoadjuvant Lenvatinib for Inoperable Thyroid Cancer: A Case Report and Literature Review." Cancer Reports (Hoboken, N.J.), vol. 5, no. 2, 2022, p. e1466, https://doi.org/10.1002/cnr2.1466.